Programme

Confirmed Speakers

​
 

• ITOC8 Lifetime Achievement Award
  Uğur Şahin and Özlem Türeci
  BioNTech SE, Mainz, Germany
  "Translating the success of the mRNA vaccine to cancer"

In alphabectical order

​

• Niroshana Anandasabapathy, Weill Cornell New York, NY, USA
   

• Mads Hald Andersen, National Center for Cancer Immune Therapy, Copenhagen, Denmark 
   

• Gregory L. Beatty, University of Pennsylvania, Philadelphia, PA, USA
   

• Marcus Bosenberg, Yale School of Medicine, New Haven, CT, USA
   

• Philippe Bousso, Department of Immunology, Institut Pasteur and INSERM, Paris, France
   

• Tullia C. Bruno, UPMC Hillman Cancer Center, Pittsburgh, PA, USA
   

• Dirk Busch, TUM, Munich, Germany
   

• Toos Daemen, University Medical Center Groningen, The Netherlands
   

• May Daher, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA
   

• Tanja de Gruijl, Cancer Center Amsterdam, The Netherlands
   

• Bernard A. Fox, Providence Portland Medical Center, Portland, OR, USA
   

• Saar Gill, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
   

• Brent Hanks, Duke University, Durham, NC, USA
   

• Maija Hollmen, University of Turku, Turku, Finland
   

• David S. Hong, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA
   

• Samuel Huber, University of Hamburg, Faculty of Medicine, Hamburg, Germany
   

• Sebastian Kobold, Ludwig-Maximilians-Universität, Munich, Germany
   

• Nicolaus Kröger, University Hospital Hamburg-Eppendorf, Hamburg, Germany
   

• X. Shirley Liu, Dana-Farber Cancer Institute and Harvard University,  Boston, MA, USA
   

• Jason J. Luke, University of Pittsburgh Medical Center, Pittsburgh PA, USA
   

• Fathia Mami-Chouaib, Institut de Cancérologie Gustave Roussy, Villejuif, France
   

• Cornelis Melief, ISA Pharmaceuticals, Leiden, The Netherlands
   

• Meriem Messaoudene, Centre Hospitalier de l'Université de Montréal, Canada
   

• Patrick A. Ott, Dana-Farber Cancer Institute, Harvard Medical School, Boston MA, USA
   

• Chong-Xian Pan, Harvard Medical School, Boston, MA, USA
   

• Stanley R Riddell, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA
   

• Marco Ruella, University of Pennsylvania, Philadelphia, PA, USA
   

• Sabina Signoretti, Harvard Medical School, Department of Pathology, Boston, MA, USA
   

• Philipp Staber, Medical University of Vienna, Austria
   

• Febe van Maldegem, The Francis Crick Institute, London, United Kingdom
   

• Michael von Bergwelt, LMU, CCC, DKTK, Munich, Germany
   

• Dietmar Zehn, Animal Physiology and Immunology, Technical University of Munich, Germany
   

​

The website is continuously updated as feedback from invited speakers is received.

Session Topics

• ​Emerging Concepts / New Agents

• Tumor microenvironment and microbiome in Immunotherapy

• Vaccine Therapy

• Pro & Contra Session

• Precision Medicine Meets Immunotherapy (Immuno-Monitoring)

• “Lost in Translation”?

• Lifetime Achievement Award

• Cell Therapy in Solid Tumors

• Cell Therapy in Haematologic Diseases

• Combination Therapy

• Young Researchers Session

• Best Poster Awards